3D-printed nanoclay-encapsulated povidone-iodine hydrogel scaffolds for osteomyelitis therapy

This is the authors' abstract. We don't add key points for this paper.

Conventional treatments for bone infections (e.g., osteomyelitis) are often plagued by incomplete eradication, antibiotic resistance, and poor biocompatibility/structural adaptability of grafts/implants, creating an urgent demand for advanced therapeutic platforms. In this context, the integration of 3D printing with antibacterial materials emerges as a promising strategy for personalized bone infection therapy. Herein, we report a novel antibacterial therapeutic system, wherein a facile fabrication approach enables the synergistic interplay of constituent materials to simultaneously enhance printability and achieve a robust antibacterial effect. The sodium alginate/methylcellulose (SAM) hydrogel inherently possesses excellent printability; upon the incorporation of hollow tubular halloysite nanotubes (HNTs) into the SAM network, the HNTs disperse uniformly, which remarkably strengthens the shear-thinning behavior of the hydrogel and improves the structural resolution of 3D-printed constructs. Furthermore, HNTs serve as efficient drug carriers for povidone-iodine (PVP-I)—a broad-spectrum antimicrobial agent that exerts potent bactericidal activity against pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) without eliciting antibiotic resistance. The resultant system exhibits superior 3D printability; after Ca 2+ cross-linking, the printed scaffolds retain the typical porous architecture of alginate-based hydrogels while demonstrating enhanced biocompatibility. Notably, in vitro experiments prove that hydrogels doped with HNTs or HNTs/PEI/PVP-I also exert a promotive effect on the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). Co-culture experiments with MRSA validate the robust antibacterial efficacy of the system, which achieves a 99% bactericidal rate within 30 minutes. Collectively, this work highlights the great potential of this 3D-printable hydrogel platform for bone infection treatment. While further in vivo validation and mechanistic exploration are warranted to fully establish its translational potential, this versatile system represents a viable candidate for the development of advanced antimicrobial scaffolds tailored for osteomyelitis therapy.